The GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTNEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
Disguised Alpha Β· CBL-514 Research

CBL-514 and Cellulite: Reading the Study Endpoints

Quick answer

CBL-514 cellulite studies concern changes in cellulite severity and appearance. Those endpoints differ from abdominal fat-volume measurements, so the results should be evaluated within the cellulite study’s own design and scales.

Disguised Alpha Β· November 11, 2026 Β· Sources reviewed November 11, 2026

What the sponsor reported

Caliway’s April 2024 topline release describes CBL-0201EFP as an open-label, two-stage program. Its second stage used a single-arm design with 23 participants, and the release reports improvements on cellulite-related scales.[1]

Those design details belong next to the outcome. A sponsor’s topline announcement is a primary statement about its program, but it is not a substitute for reviewing a full protocol, complete results tables and independent assessment.

Severity scales answer a specific question

A scale turns an observation into a defined category or score. To interpret a change, find the scoring rules, the starting severity and the threshold the investigators considered meaningful. Also identify whether the score came from a clinician, the participant or an image reviewer.

Reported measureDo not automatically translate it into
Cellulite severity scoreMilliliters of abdominal fat lost
Appearance improvement ratingA whole-body composition change
One follow-up responseA permanent effect
Single-arm changeA randomized treatment-versus-placebo difference

How to assess the strength of the evidence

Ask whether the design can distinguish treatment effects from background change, measurement variation and expectations. For an open-label study, knowing the assignment may influence some observations. That does not make the measurements meaningless; it changes the confidence and causal claims the design can support.

Track the timing of each assessment and the number of participants contributing to it. A strong response at one visit should not be silently extended to later visits that were not measured. Likewise, a result on one scale should not be substituted for a different scale simply because both refer to appearance.

Keep this program distinct from other CBL-514 indications. Shared development names do not make different populations, formulations or endpoints interchangeable, and the announcement does not validate a separately supplied research vial.

Frequently asked questions

Is a cellulite score the same as a fat-volume measurement?

No. A severity or appearance score and an imaging volume describe different outcomes.

Why does single-arm design matter?

Without a concurrent randomized comparator, a before-and-after change cannot isolate the intervention’s contribution as clearly.

CBL-514 product and documentation

Review the current format and pack choices, then match the supplied lot to its documentation. No batch-specific identity, purity or content result is asserted in this article.

Sources

  1. Caliway, April 25, 2024: CBL-0201EFP topline results

Publisher disclosure: Disguised Alpha sells the research material linked here. This supplier-published article provides research education and editorial interpretation; it is not an independent clinical review. Literature findings do not establish the identity or clinical performance of DA material.

Laboratory research only. Not for human or veterinary use. No affiliation with Caliway is claimed.

βœ“
Loading...
25% offGLPs15% off automaticallyUse code GLP or any code for 25% off0days00hrs00min00secShop the sale  →Shop